Insulet (NASDAQ:PODD – Get Rating) will be issuing its quarterly earnings data after the market closes on Thursday, May 4th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Insulet has set its FY 2023 guidance at EPS and its Q1 2023 guidance at EPS.Investors that are interested in participating […]
Insulet (NASDAQ:PODD – Get Rating) had its target price lifted by BTIG Research from $340.00 to $350.00 in a research report released on Monday morning, The Fly reports. The firm currently has a buy rating on the medical instruments supplier’s stock. A number of other equities research analysts have also weighed in on the company. […]
Insulet (NASDAQ:PODD – Get Rating) had its price objective lifted by Stifel Nicolaus from $300.00 to $342.00 in a report published on Thursday, The Fly reports. The brokerage currently has a hold rating on the medical instruments supplier’s stock. Other analysts have also issued reports about the company. Morgan Stanley boosted their target price on […]
Congress Wealth Management LLC DE increased its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 10.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,396 shares of the medical instruments supplier’s stock after purchasing an additional 624 shares during the […]